Global Protein Engineering Market Forecasted to Grow Steadily at 14.9% CAGR Between 2025 and 2029

 Use Code ONLINE20 to Save 20% On Global Market Reports — Gain Access to Trusted Market Data, Growth Indicators, and Industry Analytics

 

 How Has the Protein Engineering Market Performed Historically, and What Are Its Future Growth Projections?
 The protein engineering market size has grown rapidly in recent years. It will grow from $4.11 billion in 2024 to $4.62 billion in 2025 at a compound annual growth rate (CAGR) of 12.3%. The growth in the historic period can be attributed to scientific breakthroughs, early therapeutic success stories, biopharmaceutical revolution, rise of monoclonal antibodies, regulatory framework establishment.
 
 The protein engineering market size is expected to see rapid growth in the next few years. It will grow to $8.06 billion in 2029 at a compound annual growth rate (CAGR) of 14.9%. The growth in the forecast period can be attributed to increasing demand for therapeutic proteins, advancements in biotechnology, drug development and research, rising prevalence of chronic diseases, focus on precision medicine. Major trends in the forecast period include advanced protein design tools, high-throughput screening techniques, artificial intelligence (ai) and machine learning, novel protein expression systems, CRISPR and gene editing technologies.
 
 Get your free report sample today:
 https://www.thebusinessresearchcompany.com/sample.aspx?id=8196&type=smp
 
 What Are the Major Growth Drivers for the Protein Engineering Market?
 The increasing demand for protein-based drugs is driving the protein engineering market. Proteins that are used in drugs for therapeutic activity are protein-based drugs. The protein-based drugs or therapeutic proteins are medicines that are genetically engineered versions of naturally occurring human proteins. Protein engineering modifies protein sequences through the substitution, insertion, or deletion of nucleotides within the gene that encodes them in order to modify protein-based drugs that are better suited to particular applications. For instance, according to a study by Lancet Diabetes and Endocrinology journal, nearly 80 million people with type-2 diabetes will require insulin by 2030, a rise of 20%. Thus, increasing demand for protein-based drugs is driving the protein engineering market.
 
 What Are the Primary Market Segments in the Protein Engineering Market?
 The protein engineering market covered in this report is segmented — 
 
 1) By Product And Services: Instruments, Reagents, Services And Software 
 2) By Protein Type: Insulin, Monoclonal Antibodies, Coagulation Factors, Vaccines, Growth Factors, Other Protein Types 
 3) By Technology: Irrational Protein Design, Rational Protein Design 
 4) By End User: Pharmaceutical And Biotechnology Companies, Academic Research Institutes, Contract Research Organizations 
 
 Subsegments:
 1) By Instruments: Protein Purification Systems, Spectroscopy And Imaging Systems, Mass Spectrometers
 2) By Reagents: Enzymes, Antibodies, Labeling And Detection Reagents
 3) By Services And Software: Custom Protein Engineering Services, Analytical Services, Consulting Services, Modeling And Simulation Software, Data Analysis Software, Bioinformatics Tools
 
 
 What Are the Most Prominent Trends Impacting the Protein Engineering Market?
 Major companies operating in protein engineering are focused to provide advance protein engineering foundry for better research and industrial applications. The foundry is full-stack protein engineering foundry that allows designers to test new proteins quickly and at scale, using multiple technologies. For instance, in April 2023, Adaptyv Bio, a Switzerland-based advanced nanotechnology and biotechnology company, launched protein engineering foundry. The foundry is an integrated lab that allows protein engineers to rapidly repeat their designs and create data on their proteins, lowering reagent use, time per experiment, and cost per data point generated by orders of magnitude when compared to current methods. The foundry is being developed to integrate with AI at every stage of the protein creation cycle, from sequence design to experimental protocol planning to protocol execution and recording of all data and metadata. The objective is to democratize protein design research and accelerate the field of protein engineering.
 
 Who Are the Major Companies Operating in the Protein Engineering Market?
 Major companies operating in the protein engineering market are Bruker Corporation, Codexis Inc., Danaher Corporation, Thermo Fisher Scientific Inc., GenScript Biotech Corporation, Agilent Technologies Inc., Bio-Rad Laboratories Inc., New England Biolabs Inc., PerkinElmer Inc., Amgen Inc., InvivoGen, Enantis s.r.o., Promega Corporation, Merck KGaA, Aragen Bioscience Inc., Creative BioMart, Waters Corporation, Genentech Inc., Novartis AG, Pfizer Inc., Roche Holding AG, Sanofi S.A., GlaxoSmithKline PLC, Johnson & Johnson, Eli Lilly and Company, AbbVie Inc., Bristol-Myers Squibb Company, AstraZeneca PLC, Biogen Inc., Abzena plc. 
 
 Get the detailed protein engineering market report today
 https://www.thebusinessresearchcompany.com/report/protein-engineering-global-market-report
 
 Which Region Holds the Largest Share of the Protein Engineering Market?
 North America was the largest region in the protein engineering market share in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the protein engineering market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
 
 Contact Us:
 
 The Business Research Company 
 
 https://thebusinessresearchcompany.com/ 
 
 Americas +1 310–496–7795
 Asia +44 7882 955267 & +91 8897263534
 Europe +44 7882 955267 
 
 Email: info@tbrc.info 
 
 
 Follow Us On:
 
 LinkedIn: https://in.linkedin.com/company/the-business-research-company